ArticleCancer immunology research2022

Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4

Amrita Basu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.